Interferon-alpha and IDDM: comment.
Foulis
A K
AK
D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced / Q000276:immunology* / Q000473:pathology; D015870:Gene Expression; D006525:Hepatitis, Viral, Human / Q000628:therapy*; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000502:physiology / Q000627:therapeutic use*; D007515:Islets of Langerhans / Q000276:immunology / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic
D015395:Histocompatibility Antigens Class I; D016898:Interferon-alpha